Apligraf® commercial insurance coverage support.
When it comes to treating VLUs and DFUs, 100% of commercial medical policies cover Apligraf.*1 The commercial payer summary guidelines below show what the policies are for a number of insurance providers.
Commercial insurance coverage
of commercial medical policies cover Apligraf treatment for VLUs and DFUs*1
Commercial payer summary guidelines
Aetna Wound Care Policy #0244
Last Review 01/27/2020
Anthem Medical Coverage Policy #SURG 00011
Allogeneic, Xenographic, Synthetic and Composite Products for Wound Healing and Soft Tissue Grafting
Last review 11/7/2019
BC/BS Federal Employee Program
Bioengineered Skin and Soft Tissue Substitutes Policy #FEP7.01.113
BC/BS Highmark Commercial Medical Policy—Pennsylvania #S-33-032 & #S-249-004
Last Review 9/2019
Cigna Medical Policy #0068
Tissue-Engineered Skin Substitutes
Last review 2/15/20
Excellus Medical Coverage Policy #7.01.35
Bioengineered Tissue Products for Wound Treatment and Surgical Interventions
Last review 6/20/2019
Humana Medical Policy #HCS-0370-033
Skin and Tissue Substitutes
Last review 1/28/2020
Medica Tissue-Engineered Skin Substitutes for Wound and Surgical Care
United Health Care Commercial Medical Policy #2020T0592G
Ready to help your VLU and DFU patients?
Talk to an Organogenesis Tissue Regeneration Specialist about using Apligraf, the gold standard to heal VLUs and DFUs faster.Contact us
- Data on file. Organogenesis Inc.